Normal GFR Fluctuations in Healthy Adults
Small fluctuations in GFR are common and are not necessarily indicative of disease progression or pathology. 1
Baseline Normal GFR Values
Normal GFR in healthy adults is approximately 130 mL/min/1.73 m² for men and 120 mL/min/1.73 m² for women. 2 More recent evidence from healthy living kidney donors suggests the mean GFR is approximately 107 mL/min/1.73 m² in young adults up to age 40, with no significant difference between men and women in this age range. 3
- Reference intervals for estimated GFR in healthy adults range from approximately 63.5-139.2 mL/min/1.73 m² depending on the equation used, though values consistently remain above 60 mL/min/1.73 m² in healthy individuals. 4
- Population-based studies show median eGFR values of 104-106 mL/min/1.73 m² at age 40-45 years. 5
Age-Related Decline
The physiological decline in GFR begins after age 40 years, with a mean rate of decline of approximately 0.75 mL/min/year (or approximately 1% per year). 2, 6
- GFR remains relatively constant until age 40, after which it begins to decline in both men and women. 3
- By age 70, renal function may have declined by approximately 40% from baseline. 6
- In adults older than 70 years, values below 60 mL/min/1.73 m² could be considered normal age-related changes rather than pathological. 7
- At age 100, median eGFR drops to 45-50 mL/min/1.73 m². 5
Expected Variability and Measurement Considerations
Clinicians should recognize that small fluctuations in measured GFR are common and do not necessarily indicate true changes in kidney function. 1
- eGFR estimates can be inaccurate in non-steady-state conditions such as diabetes (hyperfiltration), extremes of muscle mass or weight (obesity, amputees), or after surgery. 2
- The accuracy of creatinine-based equations is limited, with true GFR falling outside the reported estimate in 16-20% of cases when eGFR is <60 mL/min/1.73 m². 8
- 24-hour urine collections overestimate GFR by approximately 10-20%. 2
Clinical Interpretation
When assessing GFR changes over time, confidence in progression assessment increases with increasing number of measurements and duration of follow-up. 1
- Rapid progression is defined as a sustained decline in eGFR of more than 5 mL/min/1.73 m²/year. 1
- A clinically significant drop in eGFR is defined as a drop in GFR category accompanied by a 25% or greater drop from baseline. 1
- GFR and albuminuria should be assessed at least annually in people with CKD, and more frequently in those at higher risk of progression. 1
Important Caveats
Population-based eGFR distributions show that values below the 25th percentile for age and sex are associated with increased risks of kidney failure and death, even when eGFR remains ≥60 mL/min/1.73 m². 5 This suggests that comparison to age-appropriate reference ranges, rather than fixed thresholds alone, may help identify individuals at elevated risk who warrant closer monitoring or additional diagnostic evaluation such as albuminuria testing.